查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
患者衍生异种移植 (PDX) 模型市场，按肿瘤类型、模型、最终用户、国家和地区划分 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1351394

患者衍生异种移植 (PDX) 模型市场，按肿瘤类型、模型、最终用户、国家和地区划分 - 2023-2030 年行业分析、市场规模、市场份额和预测

Patient Derived Xenograft (PDX) Model Market, By Tumor Type, By Model, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 246 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年病患衍生异种移植 (PDX) 模型市场规模为 2.906 亿美元，2023 年至 2030 年复合年增长率为 13.2%。

病患衍生异种移植 (PDX) 模型市场 - 市场动态：

  • 全球癌症盛行率的不断上升推动了市场的成长
  • 全球癌症盛行率的不断上升预计将在预测期内推动市场成长。例如，根据美国国家癌症研究所发布的报告，截至2022年1月，美国将有1,810万癌症倖存者，相当于总人口的5.4%左右。在美国，有 623,405 人患有转移性乳癌、摄护腺癌、肺癌、大肠癌、膀胱癌或黑色素瘤，到 2025 年，这一数字预计将增至 693,452 人。此外，根据英国癌症研究中心的数据，如果发病率保持稳定并且人口增长和老化继续以目前的速度进行，预计到 2040 年，全球每年将新增 2800 万癌症病例。比 2020 年增长 54.9%，预计男性（增长 60.6%）高于女性（增长 48.8%）。因此，上述事实推动了预测期内的市场成长。

患者衍生异种移植 (PDX) 模型市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，全球患者衍生异种移植 (PDX) 模型市场预计在预测期内（2023-2030 年）每年将以 13.2% 左右的复合年增长率增长
  • 由于癌症盛行率不断上升，患者衍生异种移植（PDX）模型产业预计将大幅成长。
  • 根据肿瘤类型，预计乳癌细分市场将在预测期内主导市场。
  • 从地区来看，预计北美将在预测期内主导市场。

患者衍生异种移植 (PDX) 模型市场細項分析：

  • 全球患者衍生异种移植（PDX）模型市场根据肿瘤类型、模型、最终用户和区域进行细分。
  • 根据肿瘤类型，全球患者衍生异种移植（PDX）模型市场分为摄护腺癌、胰臟癌、肺癌、乳癌等。预计乳癌细分市场将在预测期内主导市场。儘管随着时间的推移，检测和治疗方法取得了重大进步，但乳癌仍然是全世界女性死亡的主要原因。使用目前的药物，消灭肿瘤具有挑战性，因为它们由极其多样化的群体组成，包括乳癌。由于乳癌的肿瘤间异质性，使用常用的癌症模型（例如体外和体内创建的细胞系）也很难准确预测治疗效果。因此，PDX 模型的创建是为了更真实地描述人类恶性肿瘤起源的变异性。这些模型可望改善乳癌治疗方式。从而推动预测期内的细分市场成长。

患者衍生异种移植 (PDX) 模型市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。由于癌症盛行率不断上升，预计北美将在预测期内主导市场。此外，不断增加的研发投入也是推动产业扩张的重要因素。此外，该地区主要参与者的存在预计将推动市场成长。例如，2023 年 4 月，在 2023 年美国癌症研究协会 (AACR) 年会上，生物製药公司 Vincerx Pharma, Inc. 展示了一张海报： VIP236 单药疗法在不同肿瘤类型的PDX 和转移性PDX 小鼠模型中的临床前数据。因此，此类倡议预计将推动该地区的市场成长。

病患衍生异种移植（PDX）模型市场-竞争格局：

市场的主要参与者包括： WuXi AppTec、XenTech、Crown Bioscience、Altogen Labs、Envigo、Charles River Laboratories、Oncodesign、Hera Biolabs、The Jackson Laboratory 和 Abnova Corp。

最近的发展：

2022年7月，GemPharmatech（GemPharmatech Co., Ltd.）宣布与Charles River Laboratories, Inc.签订策略授权协议，独家经销其新一代NOD CRISPR Prkdc Il2r gamma（NCG）小鼠品系北美。该协议的目标是加快开发新疗法，以满足各种未满足的医疗需求，特别是免疫肿瘤学领域。为了生产将于 2023 年开始销售的模型，Charles River 将创建基础殖民地。

目录

第 1 章：病患衍生异种移植 (PDX) 模型市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按肿瘤类型分類的患者衍生异种移植 (PDX) 模型市场片段
    • 患者衍生异种移植 (PDX) 模型市场片段（按模型）
    • 最终用户的患者衍生异种移植 (PDX) 模型市场片段
    • 按国家/地区分類的患者衍生异种移植 (PDX) 模型市场片段
    • 按地区分類的患者衍生异种移植 (PDX) 模型市场片段
  • 竞争洞察

第 3 章：患者衍生异种移植 (PDX) 模型主要市场趋势

  • 患者衍生异种移植 (PDX) 模型市场驱动因素
    • 市场驱动因素的影响分析
  • 病患衍生异种移植（PDX）模型市场限制
    • 市场限制影响分析
  • 患者衍生异种移植 (PDX) 模型的市场机会
  • 病患衍生异种移植（PDX）模型市场未来趋势

第 4 章：病患来源异种移植 (PDX) 模型产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：病患衍生异种移植 (PDX) 模型市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：病患衍生异种移植 (PDX) 模型市场格局

  • 2022 年病患衍生异种移植 (PDX) 模型市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：患者衍生异种移植 (PDX) 模型市场 - 按肿瘤类型

  • 概述
    • 按肿瘤类型分類的细分市场份额分析
    • 摄护腺癌
    • 胰腺癌
    • 肺癌
    • 乳癌
    • 其他的

第 8 章：病患衍生异种移植 (PDX) 模型市场 - 按模型

  • 概述
    • 按型号分類的细分市场份额分析
    • 老鼠
    • 老鼠

第 9 章：患者衍生异种移植 (PDX) 模型市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药和生物製药公司
    • 学术及研究机构
    • CRO 和 CDMO

第 10 章：病患衍生异种移植 (PDX) 模型市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美患者源性异种移植 (PDX) 模型主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按肿瘤类型）
    • 北美市场规模和预测（按型号）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲患者源性异种移植 (PDX) 模型主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按肿瘤类型）
    • 欧洲市场规模与预测（按模型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区患者源性异种移植 (PDX) 模型主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依肿瘤类型）
    • 亚太地区市场规模与预测（按模型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲患者源性异种移植 (PDX) 模型主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按肿瘤类型）
    • 拉丁美洲市场规模和预测（按模式）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲患者源性异种移植 (PDX) 模型主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按肿瘤类型）
    • 中东和非洲市场规模及预测（按模式）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 病患衍生异种移植 (PDX) 模型产业

  • 竞争仪表板
  • 公司简介
    • WuXi AppTec
    • XenTech
    • Crown Bioscience
    • Altogen Labs
    • Envigo
    • Charles River Laboratories
    • Oncodesign
    • Hera Biolabs
    • The Jackson Laboratory
    • Abnova Corp.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1643

REPORT HIGHLIGHT

Patient Derived Xenograft (PDX) Model Market size was valued at USD 290.6 Million in 2022, expanding at a CAGR of 13.2% from 2023 to 2030.

Patient-derived xenografts (PDX) are cancer models in which a patient's tumor tissue or cells are implanted into immunocompromised or humanized mice. This procedure involves xenotransplantation. To maintain the development of cancer after it has been removed from a patient, PDX models are employed. This allows for the monitoring of tumor development in the lab, including how it responds to various therapy choices. A PDX model from a given patient can be evaluated against a variety of medicines in a 'personalized oncology' approach, or cohorts of PDX models can be used to assess the therapeutic effectiveness of a drug against distinct forms of cancer.

Patient Derived Xenograft (PDX) Model Market - Market Dynamics:

  • The growing prevalence of cancer across the globe drives the market growth
  • The growing prevalence of cancer across the globe is expected to drive market growth during the forecast period. For instance, according to the report published by National Cancer Institutes, there would be 18.1 million cancer survivors in the US as of January 2022. This is equivalent to around 5.4% of the total population. In the United States, 623,405 persons have metastatic breast, prostate, lung, colorectal, bladder, or melanoma, and by the year 2025, that number is projected to rise to 693,452. Moreover, as per the data by Cancer Research UK, it is anticipated that there will be 28 million new cancer cases globally each year by 2040 if incidence remains steady and population growth and ageing continue at current rates. This is a 54.9% increase over 2020, and it is predicted to be larger in males (60.6% increase) than in women (48.8% increase). Thus, the aforementioned facts drive the market growth during the forecast period.

Patient Derived Xenograft (PDX) Model Market - Key Insights:

  • As per the analysis shared by our research analyst, the global Patient Derived Xenograft (PDX) Model market is estimated to grow annually at a CAGR of around 13.2% over the forecast period (2023-2030)
  • Patient Derived Xenograft (PDX) Model industry is projected to grow at a significant rate owing to the growing prevalence of cancer.
  • Based on the tumor type, the breast cancer segment is expected to dominate the market over the forecast period.
  • Based on region, North America is expected to dominate the market over the forecast period.

Patient Derived Xenograft (PDX) Model Market- Segmentation Analysis:

  • The Global Patient Derived Xenograft (PDX) Model Market is segmented based on tumor type, model, end user and Region.
  • Based on the tumor type, the global Patient Derived Xenograft (PDX) Model market is segmented into prostate cancer, pancreatic cancer, lung cancer, breast cancer and others. The breast cancer segment is expected to dominate the market during the forecast period. Breast cancer still ranks as the leading cause of death for women worldwide, despite major improvements in detection and treatment methods over time. With current medicines, it is challenging to destroy tumors since they are made up of populations that are extremely varied, including those of breast cancer. Due to the inter-tumor heterogeneity of breast cancer, it is also difficult to accurately predict therapeutic efficacy using commonly used cancer models, such as cell lines created in vitro and in vivo. As a result, PDX models have been created to more realistically depict the variability of the origins of human malignancies. These models are expected to improve breast cancer therapy modalities. Thereby, driving the segment growth over the forecast period.

Patient Derived Xenograft (PDX) Model Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period due to the increasing prevalence of cancer. Moreover, the increasing R&D investments are also an important factor that propels the industry expansion. Furthermore, the presence of key players in the region is expected to propel the market growth. For instance, in April 2023, at the 2023 American Association for Cancer Research (AACR) Annual Meeting, Vincerx Pharma, Inc., a biopharmaceutical company aiming to address the unmet medical needs of cancer patients through paradigm-shifting therapeutics, presented a poster of preclinical data of VIP236 monotherapy treatment in PDX and metastatic PDX mouse models across various tumor types. Thus, this kind of initiative is expected to drive market growth in the region.

Patient Derived Xenograft (PDX) Model Market- Competitive Landscape:

The key players operating in the market are: WuXi AppTec, XenTech, Crown Bioscience, Altogen Labs, Envigo, Charles River Laboratories, Oncodesign, Hera Biolabs, The Jackson Laboratory and Abnova Corp.

Recent Developments:

In July 2022, GemPharmatech (GemPharmatech Co., Ltd.) announced that it has entered into a strategic license agreement with Charles River Laboratories, Inc. for the exclusive distribution of its next-generation NOD CRISPR Prkdc Il2r gamma (NCG) mouse lines in North America. The goal of this agreement is to speed up the development of novel therapeutics for a variety of unmet medical needs, particularly in immuno-oncology. To produce models that will be sold starting in 2023, Charles River will create foundation colonies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET KEY PLAYERS

  • WuXi AppTec
  • XenTech
  • Crown Bioscience
  • Altogen Labs
  • Envigo
  • Charles River Laboratories
  • Oncodesign
  • Hera Biolabs
  • The Jackson Laboratory
  • Abnova Corp.

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY TUMOR TYPE

  • Prostate Cancer
  • Pancreatic Cancer
  • Lung Cancer
  • Breast Cancer
  • Others

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY MODEL

  • Mice
  • Rats

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY END USER

  • Pharmaceutical And Biopharmaceutical Companies
  • Academic & Research Institutes
  • CROs & CDMOs

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Patient Derived Xenograft (PDX) Model Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Patient Derived Xenograft (PDX) Model Market Snippet by Tumor Type
    • 2.1.2. Patient Derived Xenograft (PDX) Model Market Snippet by Model
    • 2.1.3. Patient Derived Xenograft (PDX) Model Market Snippet by End User
    • 2.1.4. Patient Derived Xenograft (PDX) Model Market Snippet by Country
    • 2.1.5. Patient Derived Xenograft (PDX) Model Market Snippet by Region
  • 2.2. Competitive Insights

3. Patient Derived Xenograft (PDX) Model Key Market Trends

  • 3.1. Patient Derived Xenograft (PDX) Model Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Patient Derived Xenograft (PDX) Model Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Patient Derived Xenograft (PDX) Model Market Opportunities
  • 3.4. Patient Derived Xenograft (PDX) Model Market Future Trends

4. Patient Derived Xenograft (PDX) Model Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Patient Derived Xenograft (PDX) Model Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Patient Derived Xenograft (PDX) Model Market Landscape

  • 6.1. Patient Derived Xenograft (PDX) Model Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Patient Derived Xenograft (PDX) Model Market - By Tumor Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Tumor Type, 2022 & 2030 (%)
    • 7.1.2. Prostate Cancer
    • 7.1.3. Pancreatic Cancer
    • 7.1.4. Lung Cancer
    • 7.1.5. Breast Cancer
    • 7.1.6. Others

8. Patient Derived Xenograft (PDX) Model Market - By Model

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Model, 2022 & 2030 (%)
    • 8.1.2. Mice
    • 8.1.3. Rats

9. Patient Derived Xenograft (PDX) Model Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical And Biopharmaceutical Companies
    • 9.1.3. Academic & Research Institutes
    • 9.1.4. CROs & CDMOs

10. Patient Derived Xenograft (PDX) Model Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Patient Derived Xenograft (PDX) Model Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. WuXi AppTec
    • 11.2.2. XenTech
    • 11.2.3. Crown Bioscience
    • 11.2.4. Altogen Labs
    • 11.2.5. Envigo
    • 11.2.6. Charles River Laboratories
    • 11.2.7. Oncodesign
    • 11.2.8. Hera Biolabs
    • 11.2.9. The Jackson Laboratory
    • 11.2.10. Abnova Corp.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Patient Derived Xenograft (PDX) Model Market: Tumor Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Tumor Type
  • TABLE Global Patient Derived Xenograft (PDX) Model Market, by Tumor Type 2018-2030 (USD Million)
  • TABLE Patient Derived Xenograft (PDX) Model Market: Model Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Model
  • TABLE Global Patient Derived Xenograft (PDX) Model Market, by Model 2018-2030 (USD Million)
  • TABLE Patient Derived Xenograft (PDX) Model Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Patient Derived Xenograft (PDX) Model Market, by End User 2018-2030 (USD Million)
  • TABLE Patient Derived Xenograft (PDX) Model Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Patient Derived Xenograft (PDX) Model Market, by Region 2018-2030 (USD Million)
  • TABLE North America Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
  • TABLE North America Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
  • TABLE North America Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
  • TABLE Europe Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
  • TABLE Europe Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
  • TABLE Asia Pacific Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
  • TABLE Latin America Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
  • TABLE Latin America Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Patient Derived Xenograft (PDX) Model Market Segmentation
  • FIGURE Market research Modelology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Tumor Type segment market share analysis, 2022 & 2030
  • FIGURE Tumor Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Model segment market share analysis, 2022 & 2030
  • FIGURE Model segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Patient Derived Xenograft (PDX) Model Market share and leading players, 2022
  • FIGURE Europe Patient Derived Xenograft (PDX) Model Market share and leading players, 2022
  • FIGURE Asia Pacific Patient Derived Xenograft (PDX) Model Market share and leading players, 2022
  • FIGURE Latin America Patient Derived Xenograft (PDX) Model Market share and leading players, 2022
  • FIGURE Middle East and Africa Patient Derived Xenograft (PDX) Model Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Patient Derived Xenograft (PDX) Model Market share analysis by country, 2022
  • FIGURE Germany Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Patient Derived Xenograft (PDX) Model Market share analysis by country, 2022
  • FIGURE India Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Patient Derived Xenograft (PDX) Model Market share analysis by country, 2022
  • FIGURE Brazil Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Patient Derived Xenograft (PDX) Model Market share analysis by country, 2022
  • FIGURE Saudi Arabia Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Patient Derived Xenograft (PDX) Model Market size, forecast and trend analysis, 2018 to 2030 (USD Million)